CorrlensCorrlens
Correlate

Correlation Analysis

Broadcom Inc. Common Stock vs United Therapeutics Corp

AVGO vs UTHR

+0.895

Very strong positive

When one moves up, the other tends to follow.

AVGO logo

Broadcom Inc. Common Stock

AVGO

Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.

Market cap 1.5T

UTHR logo

United Therapeutics Corp

UTHR

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Market cap 24.5B · 1,400 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockTechnology

Time Series

Relative Performance

Green: AVGOGray: UTHR36 of 1,254 points (sampled)

Who Moves First

AVGO leads UTHR by 6 days

AVGO tends to move before UTHR.

After testing 13 timing shifts, the strongest relationship was +0.900 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.144

16 periods · Return correlation when both series rose

Both Falling

+0.889

6 periods · Return correlation when both series fell

Diverging

-0.764

13 periods · Return correlation when series moved apart

R-Squared

80.1%

Share of variance in one series explained by the other.

Trend Agreement

53.6%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.883, 0.906]

Scatter

XY Regression

20100200300400403147200300400500597Broadcom Inc. Common StockUnited Therapeutics CorpData pointsFit (r = 0.895)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

AVGO logo

Broadcom Inc. Common Stock

AVGO

Market cap 1.5T

Stock · 1,254 raw → 1,254 prepared

Series B

UTHR logo

United Therapeutics Corp

UTHR

Market cap 24.5B · 1,400 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

68

Estimated crossover points between normalized spreads.

Slope

0.8140

Linear regression slope.

Intercept

166.0870

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 5 hours ago · ID: stock-avgo-vs-stock-uthr-daily-20260408-wtzdif